Cetuximab in Combination With Chemoradiotherapy Before Surgery in Patients With Resectable, Locally Advanced Esophageal Carcinoma: A Prospective, Multicenter Phase IB/II Trial (SAKK 75/06)Thomas Ruhstaller, Viviane Hess, Roger von Moos et al.|Journal of Clinical Oncology|2011Cited by 105
Abstract P1-18-01: Incidence of hypocalcemia in patients with metastatic breast cancer under treatment with denosumab: A non-inferiority phase III trial assessing prevention of symptomatic skeletal events (SSE) with denosumab administered every 4 weeks versus every 12 weeks: SAKK 96/12 (REDUSE)AMANDA OLGA MÜLLER, Roger von Moos, AJ Templeton et al.|Cancer Research|2019Cited by 2